Selective Attenuation by N-0861 (M-Endonorboran-2-yl-9-Methyladenine) of Cardiac A1 Adenosine Receptor-Mediated Effects in Humans

Circulation

Volumn 93, Issue 10, 1996, Pages 1871-1876

  Bertolet, Barry D ^a,b   Belardinelli, Luiz ^a   Franco, Elizabeth A ^a   Nichols, Wilmer W ^a   Kerensky, Richard A ^a   Hill, James A ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Adenosine; Circulation; Electrophysiology; Purinergic; Receptors

Indexed keywords

9 METHYL 6 N (2 NORBORNYL)ADENINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; HEART RECEPTOR;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; DRUG SELECTIVITY; FEMALE; HEART CATHETERIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; THORAX PAIN;

ADENINE; ADENOSINE; AGED; CORONARY CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; NORBORNANES; PAIN; RECEPTORS, PURINERGIC P1;

EID: 0029932943     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.10.1871     Document Type: Article

References (26)

1. Schrader J. Metabolism of adenosine and sites of production in the heart. In: Berne RM, Rall TW, Rubio R, eds. Regulatory Function of Adenosine. Boston, Mass: Martinus Nijhoff; 1983:133-149.
2. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis. 1989;32:73-97.
3. Verani MS. Adenosine thallium 201 myocardial perfusion scintigraphy. Am Heart J. 1991;122:269-278.
4. Abreu A, Mahmarian JJ, Nishumura S, Boyce TM, Verani MS. Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease. J Am Coll Cardiol. 1991;18: 730-735.
5. Cave V, Heo J, Cassel D, Iskandrian B, Iskandrian AS. Side effects during adenosine thallium imaging with single-port or double-port infusion protocols. Am Heart J. 1992;124:610-613.
6. O'Keefe JH Jr, Bateman TM, Silvestri R, Barnhart C. Safety and diagnostic accuracy of adenosine thallium-201 scintigraphy in patients unable to exercise and those with left bundle branch block. Am Heart J. 1992;124:614-621.
7. 1 subtype-selective adenosine receptor antagonist in the guinea pig isolated heart. J Pharmacol Exp Ther. 1992;260:1292-1299.
8. 1 adenosine receptor in the anaesthetized pig: pharmacological and therapeutic implications. Cardiovasc Res. 1994;28:621-628.
9. Belardinelli L, Fenton RA, West A, Linden J, Althaus JS, Berne RM. Extracellular action of adenosine and the antagonism by aminophylline on the atrioventricular conduction of isolated perfused guinea pig and rat hearts. Circ Res. 1982;51:569-579.
10. May JM, Martin PL, Miller JR. N-0861: a selective A1-receptor antagonist. FASEB J. 1991;5:A1572. Abstract.
11. 1 receptor antagonist, in patients receiving adenosine. J Am Coll Cardiol. 1994;February:478A. Abstract.
12. 1-antagonist. Drug Fut. 1993;18:433-435.
13. Egashire K, Inou T, Hirooka Y, Yamada A, Maruoka Y, Kai H, Sugimachi M, Suzuki S, Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest. 1993;91:29-37.
14. Winniford MD, Lambert CR. Blood flow measurement. In: Pepine CJ, Hill JA, Lambert CR, eds. Diagnostic and Therapeutic Cardiac Catheterization. Baltimore, Md: Williams & Wilkins; 1994:321-354.
15. Hartley CJ. Review of intracoronary Doppler catheters. Int J Card Imaging. 1989;4:159-168.
16. Handiandreou NJ, Toggart EJ, Mistretta CA. Investigation of the performance of two types of the Doppler catheter in vitro. Cathet Cardiovasc Diagn. 1989;18:108-117.
17. Sylven C, Beermann B, Jonzon B, Brandt R. Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers. Br Med J. 1986;293:227-230.
18. Lagerqvist B, Sylven C, Theodorsen E, Kaijser L, Helmius G, Waldenstrom A. Adenosine induced chest pain: a comparison between intracoronary bolus injection and steady state infusion. Cardiovasc Res. 1992;26:810-814.
19. 6-endonorbornan-2-yl-9-methyladenine). J Am Coll Cardiol. 1995;February:127A. Abstract.
20. Wesley RC Jr, Lerman BB, DiMarco JP, Berne RM, Belardinelli L. Mechanism of atropine-resistant atrioventricular block during inferior myocardial infarction: possible role of adenosine. J Am Coll Cardiol. 1986;8:1232-1234.
21. Bertolet BD, McMurtrie EB, Hill JA, Belardinelli L. Theophylline for myocardial infarction related AV block. Ann Intern Med. 1995; 123:509-511.
22. Saito D, Matsubara K, Yamanari H, Obayashi N, Uchida S, Mekawa K, Sato T, Mizuo K, Kobayashi H, Haraoka S. Effects of oral theophylline on sick sinus syndrome. J Am Coll Cardiol. 1993; 21:1199-1204.
23. Viskin S, Belhassen B, Roth A, Reicher M, Averbuch M, Sheps D, Shalabye E, Laniado S. Aminophylline for bradyasystolic cardiac arrest refractory to atropine and epinephrine. Ann Intern Med. 1993;118:279-281.
24. Haught WH, Bertolet BD, Conti JB, Curtis AB, Mills RM Jr. Theophylline reverses high-grade atrioventricular block resulting from cardiac transplant rejection. Am Heart J. 1994;128:1255-1257.
25. Ellenbogen KA, Szentpetery S, Katz MR. Reversibility of prolonged chronotropic dysfunction with theophylline following orthotopic cardiac transplantation. Am Heart J. 1988;116:202-206.
26. Lerman BB, Engelstein ED. Metabolic determinants of defibrillation: role of adenosine. Circulation. 1995;91:838-844.